Profil
Jayne M.
Gansler served as Senior Vice President of Human Resources at ARIAD Pharmaceuticals, Inc. She also held the position of Senior Vice President of Global Human Resources at Genzyme Corp.
from 2002 to 2011.
Recently, she served as Chief People Officer and Executive Vice President at Seres Therapeutics, Inc. from 2020 to 2022.
Gansler received her undergraduate degree from the University of Massachusetts.
Anciens postes connus de Jayne M. Gansler
| Sociétés | Poste | Fin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Responsable des Ressources Humaines | 07/02/2022 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Responsable des Ressources Humaines | 01/01/2011 |
| ARIAD PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | - |
Formation de Jayne M. Gansler
| University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
